The duo launched on a SpaceX Falcon 9 rocket at 11:10 p.m. EST (0310 March 12 GMT). There was a glimmer in the air tonight at Vandenberg Space Force Base in California, and it wasn't only because ...
Kyowa Kirin, Amgen’s rocatinlimab ignites positive response in Rocket study Analysts were pleasantly surprised by the positive phase III data reported for Kyowa Kirin Co. Ltd./Amgen Inc.’s ...
Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...
The payload is the next batch of SpaceX's Starlink internet satellites. As it flies into the night sky, the rocket will travel southeast from the launch pad. When is the next launch? Is there a ...
Amgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET program that is evaluating the investigational anti-OX40 therapy ...
Amgen and Kyowa Kirin have reported that the 24-week Phase III IGNITE trial assessing two dose strengths of the T-cell rebalancing therapy, rocatinlimab, in individuals with moderate to severe ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- A ...
Across the Phase III ROCKET programme, the safety findings have been consistent with the known safety profile of the therapy. This programme consists of eight trials, aiming to “establish” the therapy ...
March 8 from the launch of NASA's SPHEREx mission from Vandenberg, CA to further investigate the recent Falcon 9 rocket issues. Original story: Will tonight be the night SpaceX's Starlink 12-21 ...
Just a few hours before the planned launch on Saturday, the decision was made to stand down from the mission to allow teams to continue rocket checkouts ahead of liftoff. A new launch date and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results